GEFVB – SESSION 1 – IMMUNOTHERAPY IN INTERMEDIATE-STAGE HCC: FROM CLINICAL CHALLENGES TO OPTIMIZING HOSPITAL PATHWAYS
DATE: 19-11-2026
TIME: 17:30 / 18:05
DURATION: 35 minutes
LOCATION: Room A
New Clinical Challenges in the Treatment of Intermediate-Stage HCC
How to adapt hospital pathways to the new therapeutic landscape
Discussion